Ronald Meeusen
Managing Director @ Cultivian Sandbox Ventures
Chicago, United States
Ronald Meeusen is a Series B investor at Cultivian Sandbox Ventures in Chicago focused on Health Care and Biotechnology. Ronald Meeusen is the Managing Director of Cultivian Sandbox Ventures. He previously worked at ImmuneWorks as a CEO and Founder. Ronald Meeusen attended the University of Wisconsin-Milwaukee and the University of California, Berkeley.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ronald Meeusen invests in
Stages Ronald Meeusen invests in
Countries Ronald Meeusen invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aratana Therapeutics
|
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercialproducts for companion animals in a cost effective and efficient manner. | $15M / Series B / Dec 07, 2011 |
Co-Investors
About Cultivian Sandbox Ventures
Cultivian Sandbox is a venture capital firm focused on building next-generation disruptive agriculture and food technology companies capable of generating superior returns. As early investors and active board members, we employ a hands-on approach to building companies and are often directly involved in setting company strategy, recruiting keyexecutives, and raising additional capital. Much more than simply a financial resource, we are capable of delivering tremendous value though active collaboration with our strategic partners and network, which are unparalleled in the agriculture and food industries.As both experienced operating managers and venture investors we add value to portfolio companies both through our highly skilled team and extensive industry network. Our investment team combines the domain expertise and investment experience from Cultivian Ventures and Sandbox Industries. Our expertise in sourcing, evaluating, closing, managing and ultimately exiting successful equity investments positions us not only to build stronger businesses, but reshape industries.
Cultivian Sandbox Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amanda Donohue-Hansen
Managing Director
|
|||
Ariel Choi
General Counsel
|
|||
Dan Phillips
Managing Director
|
|||
Robert Shapiro
Managing Director
|
|||
|
Ronald Meeusen
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ronald Meeusen invest in?
Ronald Meeusen invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ronald Meeusen last invest?
The most recent investment recorded for Ronald Meeusen closed in Dec 2011. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
